Introduction: Breast cancer (BC) is one of the most common health concerns among women and is the leading cause of cancer-related death around the world. Women, in particular young women, face unique and complex problems with BC. Physical, psychological, emotional, educational, and long-term BC-related problems have been recognized for these vulnerable populations. Besides BC patients, their families and relatives challenge with various problems such as financial and supportive issues in supporting these patients. Methods: The main objective of the present study was to evaluate the BC patient’s major problems and describe current supportive initiatives and programs that support these patients, their advancements to date, existing challenges, and possible future actions. Data collection took place by conducting a comprehensive search on the Internet, Medline, PubMed, and Google Scholar databases. We also discuss the contingency options, which lead to improving medical and supportive care, as well as overcoming barriers to providing comprehensive and optimal care and support for these unique groups of patients. Results: The result revealed that several comprehensive and well-developed BC programs and initiatives have been established around the world for providing and focusing on BC patient’s clinical care, supportive care, education, survivorship, navigation, and research. However, despite considerable advancement in this area, there are still significant challenges in addressing the BC patient’s needs. Conclusion: Evaluation of the current situation of BC patient’s treatment and quality of life highlighted the importance of developing and implementing the new and most efficient healthcare programs and protocols, as well as improving and optimizing the existing ones to improve and enhance the survival rate and quality of life of BC patients.

Journal Section:
Systematic Review
Keywords:
Cancer, Breast cancer, Breast cancer issues, Breast cancer programs
1.
Harris JR, Lippman ME, Veronesi U, Willett W. Breast cancer. N Engl J Med. 1992;327(5):319–28. <
2.
World health organization. https://www.who.int/news-room/fact-sheets/detail/breast-cancer.
3.
Breast cancer survivors. https://www.wcrf.org/dietandcancer/breast-cancer-survivors/.
4.
Wei XYL, Liu XY, Chen YY, Zhou X, Hu HP. Effectiveness of physical, psychological, social, and spiritual intervention in breast cancer survivors: an integrative review. Asia-Pacific J Oncol Nurs. 2016;3(3):226–32.
5.
Dorri S, Olfatbakhsh A, Asadi F. Informational needs in patients with breast cancer with lymphedema: is it important? Breast Cancer. 2020;14:1178223420911033.
6.
Lovelace DL, McDaniel LR, Golden D. Long-term effects of breast cancer surgery, treatment, and survivor care. J Midwifery Womens Health. 2019;64(6):713–24.
7.
Yip C, Buccimazza I, Hartman M, Deo SV, Cheung PS. Improving outcomes in breast cancer for low and middle income countries. World J Surg. 2015;39(3):686–92.
8.
Yip CH, Taib NA. Challenges in the management of breast cancer in low- and middle-income countries. Future Oncol. 2012;8(12):1575–83.
9.
Bodai BI, Tuso P. Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations. Perm J. 2015;19(2):48–79.
10.
Howes BH, Watson DI, Xu C, Fosh B, Canepa M, Dean NR. Quality of life following total mastectomy with and without reconstruction versus breast-conserving surgery for breast cancer: a case-controlled cohort study. J Plast Reconstr Aesthet Surg. 2016;69(9):1184–91.
11.
Hidding JT, Beurskens CH, van der Wees PJ, van Laarhoven HW, Nijhuis-van der Sanden MW. Treatment related impairments in arm and shoulder in patients with breast cancer: a systematic review. PLoS One. 2014;9(5):e96748.
12.
Wong IO, Cowling BJ, Schooling CM, Leung GM. Age-period-cohort projections of breast cancer incidence in a rapidly transitioning Chinese population. Int J Cancer. 2007;121(7):1556–63.
13.
Azim HA, Partridge AH. Biology of breast cancer in young women. 2014;16(4):427.
14.
Anders CK, Johnson R, Litton J, Phillips M, Bleyer A. Breast cancer before age 40 years. Semin Oncol. 2009;36(3):237–49.
15.
Beadle BM, Woodward WA, Buchholz TA. The impact of age on outcome in early-stage breast cancer. Semin Oncol Nurs. 2011;21(1):26–34.
16.
Gabriel CA, Domchek SM. Breast cancer in young women. Breast Cancer Res. 2010;12(5):212.
17.
Rosenberg SM, Newman LA, Partridge AH. Breast cancer in young women. JAMA Oncol. 2015;1(7):877–8.
18.
Rossi L, Mazzara C, Pagani O. Diagnosis and treatment of breast cancer in young women. Curr Treat Options Oncol. 2019;20(12):86–14.
19.
Villarreal-Garza C, Platas A, Miaja M, Fonseca A, Mesa-Chavez F, Garcia-Garcia M, et al. Young women with breast cancer in Mexico: results of the pilot phase of the Joven & Fuerte prospective cohort. JCO Glob Oncol. 2020;6(6):395–406.
20.
Reto G. Grupo Reto. Grupo de Recuperación Total: apoyo a mujeres con cáncer mamario; 2003.
21.
Harrison LB, Ferlito A, Shaha AR, Bradley PJ, Genden EM, Rinaldo A. Current philosophy on the management of cancer of the base of the tongue. Oral Oncol. 2003;39(2):101–5.
22.
Biganzoli L. The requirements of a specialist breast centre; 2020.
23.
Agarwal GRP, Ramakant ER, Forgach JC, Rendón JM, Chaparro CS, Basurto M, et al. Breast cancer care in developing countries. World J Surg. 2009 Oct;33(10):2069–76.
24.
Villarreal-Garza C, Martinez-Cannon BA, Platas A, Ramos-Elias P. Specialized programs to support young women with breast cancer. Curr Opin Support Palliat Care. 2015;9(3):308–16.
25.
Ali A, Warner E. PYNK: breast cancer program for young women. Curr Oncol. 2013;20(1):e34–9.
26.
Cancer.Net. https://www.cancer.net/cancer-types/breast-cancer/types-treatment.
27.
McMullen L. Oncology nurse navigators and the continuum of cancer care. Semin Oncol Nurs. 2013;29(2):105–17.
28.
Cantril C, Haylock PJ. Patient navigation in the oncology care setting. Semin Oncol Nurs. 2013;29(2):76–90.
29.
Koh C, Nelson JM, Cook PF. Evaluation of a patient navigation program. Clin J Oncol Nurs. 2011;15(1):41–8.
30.
Villarreal-Garza C, C, Platas A, Miaja M, Mohar-Betancourt A, Barragan-Carrillo R, et al. “Joven & Fuerte”: program for young women with breast cancer in Mexico – initial results. Rev Invest Clin. 2017;69(4):223–8.
31.
Taylor C, Shewbridge A, Harris J, Green JS. Benefits of multidisciplinary teamwork in the management of breast cancer. Breast Cancer. 2013;5:79–85.
32.
Reyna C, Lee MC. Breast cancer in young women: special considerations in multidisciplinary care. J Multidiscip Healthc. 2014;7:419–29.
33.
Coughlin SS, Ekwueme DU. Breast cancer as a global health concern. Cancer Epidemiol. 2009;33(5):315–8.
34.
Yip C, Taib NA, Song CV, Pritam Singh RK, Agarwal G. Early diagnosis of breast cancer in the absence of population-based mammographic screening in Asia. Curr Breast Cancer Rep. 2018;10(3):148–56.
35.
Mohindra N, Neyaz Z, Agrawal V, Agarwal G, Mishra P. Impact of addition of digital breast tomosynthesis to digital mammography in lesion characterization in breast cancer patients. Int J App Basic Med Res. 2018;8(1):33.
36.
Noreen M, Murad S, Furqan M, Sultan A, Bloodsworth P. Knowledge and awareness about breast cancer and its early symptoms among medical and non-medical students of southern Punjab, Pakistan. Asian Pac J Cancer Prev. 2015;16(3):979–84.
37.
Anderson DS, Distelhorst SR. Guidelines for International Breast Health and Cancer Control: implementation. Introduction. Cancer. 2008 Oct 15;113(8 Suppl l):2215–6.
38.
The Breast Health Global Initiative. https://www.who.int/cancer/bghi.pdf?ua=1.PDF.
39.
Anderson BO, Tsu VD. Breast cancer in low and middle income countries: how can guidelines best be disseminated and implemented? Breast Care. 2008;3(1):6–8.
40.
Anderson BO, Yip CH, Smith RA, Shyyan R, Sener SF, Eniu A, et al. Guideline implementation for breast healthcare in low-income and middle-income countries: overview of the Breast Health Global Initiative Global Summit 2007. Cancer. 2008;113(S8):2221–43.
41.
Anderson BO, Cazap E, El Saghir NS, Yip CH, Khaled HM, Otero IV, et al. Optimisation of breast cancer management in low-resource and middle-resource countries: executive summary of the Breast Health Global Initiative consensus, 2010. Lancet Oncol. 20102011;12(4):387–98.
42.
Anderson BO, Braun S, Carlson RW, Gralow JR, Lagios MD, Lehman C, et al. Overview of breast health care guidelines for countries with limited resources. Breast J. 2003;9 Suppl 2:S42–50.
43.
El Saghir NS, Adebamowo CA, Anderson BO, Carlson RW, Bird PA, Corbex M, et al. Breast cancer management in low resource countries (LRCs): consensus statement from the Breast Health Global Initiative. Breast. 2011;20:S3S11.
44.
Anderson BO, Shyyan R, Eniu A, Smith RA, Yip CH, Bese NS, et al. Breast cancer in limited-resource countries: an overview of the Breast Health Global Initiative 2005 guidelines. Breast J. 2006;12 Suppl 1:S3–15.
45.
Gelband H, Sloan FA. Cancer control opportunities in low-and middle-income countries. National Academies Press; 2007.
46.
Ganz PA, Yip CH, Gralow JR, Distelhorst SR, Albain KS, Andersen BL, et al. Supportive care after curative treatment for breast cancer (survivorship care): resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement. Breast. 2013;22(5):606–15.
47.
Paluch-Shimon S, Cardoso F, Partridge AH, Abulkhair O, Azim HA, Bianchi-Micheli G, et al. ESO-ESMO 4th international consensus guidelines for breast cancer in young women (BCY4). Ann Oncol. 2020;31(6):674–96.
48.
Sgpgi-Breast Health Programme. Activities and achievements; 2020. http://sgpgibreasthealth.org.in/activities.htmSGPGI-Breast.
49.
Runowicz CD, Leach CR, Henry NL, Henry KS, Mackey HT, Cowens-Alvarado RL, et al. American cancer society/American society of clinical oncology breast cancer survivorship care guideline. CA Cancer J Clin. 2016;66(1):43–73.
50.
Ashbury FD, Cameron C, Mercer SL, Fitch M, Nielsen E. One-on-one peer support and quality of life for breast cancer patients. Patient Educ Couns. 1998;35(2):89–100.
51.
Rankin N, Williams P, Davis C, Girgis A. The use and acceptability of a one-on-one peer support program for Australian women with early breast cancer. Patient Educ Couns. 2004;53(2):141–6.
52.
Lawson AK, Klock SC, Pavone ME, Hirshfeld-Cytron J, Smith KN, Kazer RR. Psychological counseling of female fertility preservation patients. J Psychosocial Oncol. 2015;33(4):333–53.
53.
Loren AW, Mangu PB, Beck LN, Brennan L, Magdalinski AJ, Partridge AH, et al. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;31(19):2500.
54.
Partridge AH, Ruddy KJ, Kennedy J, Winer EP. Model program to improve care for a unique cancer population: young women with breast cancer. J Oncol Pract. 2012;8(5):e105–10.
55.
Ellegaard M-BB, Grau C, Zachariae R, Bonde Jensen A. Fear of cancer recurrence and unmet needs among breast cancer survivors in the first five years. A cross-sectional study. Acta Oncologica. 2017;56(2):314–20.
56.
So WK, Chow KM, Chan HY, Choi KC, Wan RW, Mak SS, et al. Quality of life and most prevalent unmet needs of Chinese breast cancer survivors at one year after cancer treatment. Eur J Oncol Nurs. 2014;18(3):323–8.
57.
Cohen L, Hamer J, Helwig C, Fergus K, Kiss A, Mandel R, et al. Formal evaluation of PYNK: breast cancer program for young women-the patient perspective. Curr Oncol. 2016;23(2):e102–8.
58.
Fallowfield L, Jenkins VJ. Psychosocial/survivorship issues in breast cancer: are we doing better? J Natl Cancer Inst. 2015;107(1):335.
59.
Mehnert A, Koch UJ. Psychological comorbidity and health-related quality of life and its association with awareness, utilization, and need for psychosocial support in a cancer register-based sample of long-term breast cancer survivors. J Psychosom Res. 2008;64(4):383–91.
60.
Wong-Kim EC, Bloom JR. Depression experienced by young women newly diagnosed with breast cancer. Psychooncology. 2005;14(7):564–73.
61.
Baucom DH, Porter LS, Kirby JS, Gremore TM, Keefe FJ. Psychosocial issues confronting young women with breast cancer. Breast Dis. 2006;23(1):103–13.
62.
Ferrante JM, Chen PH, Kim SJ. The effect of patient navigation on time to diagnosis, anxiety, and satisfaction in urban minority women with abnormal mammograms: a randomized controlled trial. J Urban Health. 2008;85(1):114–24.
63.
Hoffman HJ. Patient navigation significantly reduces delays in breast cancer diagnosis in the District of Columbia. AACR; 2012.
64.
Wu TY, Lee J. Promoting breast cancer awareness and screening practices for early detection in low-resource settings. Eur J Breast Health. 2019;15(1):18–25.
65.
Rana P, Ratcliffe J, Sussman J, Forbes M, Levine M, Hodgson N. Young women with breast cancer: needs and experiences. Cogent Med. 2017;4(1):1278836.
66.
Fernandes-Taylor S, Adesoye T, Bloom JR. Managing psychosocial issues faced by young women with breast cancer at the time of diagnosis and during active treatment. Curr Opin Support Palliat Care. 2015;9(3):279.
67.
Lee KY, Mooney DJ. Alginate: properties and biomedical applications. Prog Polym Sci. 2012;37(1):106–26.
68.
Kaiser K, Cameron KA, Curry G, Stolley M. Black women’s awareness of breast cancer disparity and perceptions of the causes of disparity. J Community Health. 2013;38(4):766–72.
69.
Jones CE, Maben J, Lucas G, Davies EA, Jack RH, Ream E. Barriers to early diagnosis of symptomatic breast cancer: a qualitative study of Black African, Black Caribbean and White British women living in the UK. BMJ Open. 2015;5(3):e006944.
70.
Gould J, Grassau P, Manthorne J, Gray RE, Fitch MI. 'Nothing fit me’: nationwide consultations with young women with breast cancer. Health Expect. 2006;9(2):158–73.
71.
Quinn VS, Vadaparampil JH, Lee PB, Jacobsen G, Bepler J, Lancaster DL, et al. Physician referral for fertility preservation in oncology patients: a national study of practice behaviors. J Clin Oncol. 2009 Dec 10;27(35):5952–7.
72.
Chua GP, Tan HK. A qualitative approach in determining the patient-centered information and supportive care needs of cancer patients in Singapore. BMJ Open. 2020;10(2):e034178.
73.
Choy E, Chiu A, Butow P, Young J, Spillane A. A pilot study to evaluate the impact of involving breast cancer patients in the multidisciplinary discussion of their disease and treatment plan. Breast. 2007;16(2):178–89.
74.
Cimprich B, Janz NK, Northouse L, Wren PA, Given B, Given CW. Taking CHARGE: a self-management program for women following breast cancer treatment. Psychooncology. 2005;14(9):704–17.
75.
Tazhibi M, Feizi A. Awareness levels about breast cancer risk factors, early warning signs, and screening and therapeutic approaches among Iranian adult women: a large population based study using latent class analysis. Biomed Res Int. 2014;2014:306352.
76.
Luctkar-Flude MF. Challenges, strengths and opportunities related to implementing comprehensive evidence-based guidelines on breast cancer survivorship care by primary care physicians and nurse practitioners in Southeastern Ontario. Queen's University; 2016.
77.
Pereira AAC, Destro JR, Picinin Bernuci M, Garcia LF, Rodrigues Lucena TF. Effects of a WhatsApp-delivered education intervention to enhance breast cancer knowledge in women: mixed-methods study. JMIR Mhealth Uhealth. 2020;8(7):e17430.
78.
Thushara K, Gnanakumar ES, Mathew R, Jha RK, Ajithkumar TG, Rajamohanan PR, et al. Toward an understanding of the molecular level properties of Ziegler−Natta catalyst support with and without the internal electron donor. J Phys Chem C. 2011;115(5):1952–60.
79.
Zhang B, Zhang L, Fu Z, Fan Z. Effect of internal electron donor on the active center distribution in MgCl2-supported Ziegler-Natta catalyst. Catal Commun. 2015;69:147–9.
80.
Cheng RH, Luo J, Liu Z, Sun JW, Huang WH, Zhang MG, et al. Adsorption of TiCl4 and electron donor on defective MgCl2 surfaces and propylene polymerization over Ziegler-Natta catalyst: a DFT study. Chin J Polym Sci. 2013;31(4):591–600.
81.
Abboud M, Denifl P, Reichert K-H. Advantages of an emulsion-produced ziegler-natta catalyst over a conventional ziegler-natta catalyst. Macromol Mater Eng. 2005;290(12):1220–6.
82.
Ning Y. Progress in research and application of Ziegler-Natta catalysts for Unipol polyethylene production [J]; 2010. p. 4.
83.
Walsh DJ, Hyatt MG, Miller SA, Guironnet D. Recent trends in catalytic polymerizations. ACS Catal. 2019;9(12):11153–88.
84.
Curry SJ, Byers T, Hewitt M. Fulfilling the potential of cancer prevention and early detection in federal programs that support cancer prevention and early detection. National Academies Press (US); 2003.
85.
Partridge AH. Cancer survivorship and the young breast cancer patient: addressing the important issues. Oncologist. 2013;18(8):e19–20.
86.
Zhu L Effects of Ti/Mg molar ratio on bi-supported SiO2/MgCl2 (ethoxide type)/TiCl4 catalysts in ethylene homopolymerization and ethylene/1-hexene copolymerization. 2018. 5(1):1–13.
87.
Agarwal G, Ramakant P. Breast cancer care in India: the current scenario and the challenges for the future. Breast Care. 2008;3(1):21–7.
88.
Al-Azmy, SF Practicing breast self-examination among women attending primary health care in Kuwait. 2013. 49(3):281–6.
89.
Adams E, Boulton M, Watson E. The information needs of partners and family members of cancer patients: a systematic literature review. Patient Educ Couns. 2009;77(2):179–86.
90.
Awadalla AW, Ohaeri JU, Gholoum A, Khalid AO, Hamad HM, Jacob A. Factors associated with quality of life of outpatients with breast cancer and gynecologic cancers and their family caregivers: a controlled study. BMC Cancer. 2007;7(1):102.
91.
Takahashi MJBC. Psychosocial distress among young breast cancer survivors: implications for healthcare providers. Breast Cancer. 2014;21(6):664–9.
92.
Agarwal G, Ramakant P, Forgach ER, Rendón JC, Chaparro JM, Basurto CS, et al. Breast cancer care in developing countries. World J Surg. 2009;33(10):2069.
93.
Williams TJ, Lamb JV, Buffet J-C, Khamnaen T, O'Hare D. Synthesis of ultra-high molecular weight poly(ethylene)-co-(1-hexene) copolymers through high-throughput catalyst screening. RSC Adv. 2021;11(10):5644–50.
94.
Adams E, McCann L, Armes J, Richardson A, Stark D, Watson E, et al. The experiences, needs and concerns of younger women with breast cancer: a meta-ethnography. Psychooncology. 2011;20(8):851–61.
95.
Cazap E, Buzaid AC, Garbino C, de la Garza J, Orlandi FJ, Schwartsmann G, et al. Breast cancer in Latin America. Cancer. 2008;113(S8):2359–65.
96.
Paladini F, Pollini M, Sannino A, Ambrosio L. Metal-based antibacterial substrates for biomedical applications. Biomacromolecules. 2015;16(7):1873–85.
97.
Fiedot-Toboła, M. Deposition of zinc oxide on different polymer textiles and their antibacterial properties. Materials. 2018;11(5):707.
98.
Villarreal-Garza C. Clinicopathological characteristics and outcomes of the ongoing “Joven & Fuerte” Cohort of young women with breast cancer in Mexico. Am Soc Clin Oncol. 2018;4(2.
99.
Rodríguez-Tobías H, Morales G, Grande D. Comprehensive review on electrospinning techniques as versatile approaches toward antimicrobial biopolymeric composite fibers. Mater Sci Eng C Mater Biol Appl. 2019;101:306–22.
100.
Vančo, M, Krmela J, Pešlová F, The use of PVD coating on natural textile fibers. Proc Eng. 2016. 136:341–5.
101.
Yetisen AK, Qu H, Manbachi A, Butt H, Dokmeci MR, Hinestroza JP, et al. Nanotechnology in textiles. ACS Nano. 2016;10(3):3042–68.
102.
Anderson BO, Yip CH, Ramsey SD, Bengoa R, Braun S, Fitch M, et al. Breast cancer in limited-resource countries: health care systems and public policy. Breast J. 2006;12 Suppl 1:S54–69.
© 2022 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2022
You do not currently have access to this content.